Results Patient characteristics 58 pairs were matched successfully, one 27-year old patienttreated with gefitinib failed to be matched because of theage. Among the 116 patients, 58 patients with the treatment of gefitinib plus CHM and 58 patients with the singledrug treatment of gefitinib (control group). The base-line characteristics of patients are given in Table 1.